234 related articles for article (PubMed ID: 1856733)
1. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Chen ZW; Cook SD
J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to sulfated glycolipids in Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Dalakas MC; Wargo M; Chen ZW; Bielory L; Cook SD
J Neurol Sci; 1991 Sep; 105(1):108-17. PubMed ID: 1795163
[TBL] [Abstract][Full Text] [Related]
3. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
[TBL] [Abstract][Full Text] [Related]
7. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
8. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Yuki N; Tagawa Y; Handa S
J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes.
Shahrizaila N; Kokubun N; Sawai S; Umapathi T; Chan YC; Kuwabara S; Hirata K; Yuki N
Neurology; 2014 Jul; 83(2):118-24. PubMed ID: 24920848
[TBL] [Abstract][Full Text] [Related]
11. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
[TBL] [Abstract][Full Text] [Related]
12. Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons.
Mithen FA; Ilyas AA; Birchem R; Cook SD
J Neurol Sci; 1992 Oct; 112(1-2):223-32. PubMed ID: 1469435
[TBL] [Abstract][Full Text] [Related]
13. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
[TBL] [Abstract][Full Text] [Related]
14. Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies.
Morikawa M; Kuwahara M; Ueno R; Samukawa M; Hamada Y; Kusunoki S
J Neuroimmunol; 2016 Dec; 301():35-40. PubMed ID: 27836184
[TBL] [Abstract][Full Text] [Related]
15. Anti asialo GM1 antibody detected in the patients' sera from systemic lupus erythematosus and Behçet's diseases with neurological manifestations.
Hirano T; Miyajima H; Taniguchi O; Ueda A; Takai S; Hashimoto H; Hirose S; Okumura K
Jpn J Med; 1988 May; 27(2):167-71. PubMed ID: 3418980
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to gangliosides in Guillain-Barré syndrome.
Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.
Rinaldi S; Brennan KM; Kalna G; Walgaard C; van Doorn P; Jacobs BC; Yu RK; Mansson JE; Goodyear CS; Willison HJ
PLoS One; 2013; 8(12):e82337. PubMed ID: 24358172
[TBL] [Abstract][Full Text] [Related]
19. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
